Preview Mode Links will not work in preview mode

Mar 26, 2020

Proceedings from a CME symposium held at the 2020 Genitourinary Cancer Symposium. Featuring perspectives from Drs Peter H O’Donnell, Daniel P Petrylak, Elizabeth R Plimack, Jonathan E Rosenberg and Guru Sonpavde.

  • Introduction
    • Program Overview: Dr Neil Love (00:00)
  • Immune Checkpoint Inhibitors for Patients with Nonmetastatic Urothelial Bladder Cancer (UBC)
    • Roundtable Discussion (1:05)
    • Faculty Presentation — Dr Plimack (13:05)
  • Role of Anti-PD-1/PD-L1 Antibodies in the Up-Front Management of Advanced UBC
    • Roundtable Discussion (25:17)
    • Faculty Presentation — Dr Rosenberg (39:50)
  • Application of Anti-PD-1/PD-L1 Antibodies for Progressive Metastatic Disease; Ongoing Investigation of Immune Checkpoint Inhibitors in Advanced UBC
    • Roundtable Discussion (54:11)
    • Faculty Presentation — Dr O’Donnell (1:02:25)
  • Approved and Investigational Antibody-Drug Conjugates for Advanced UBC
    • Roundtable Discussion (1:13:41)
    • Faculty Presentation — Dr Petrylak (1:23:53)
  • FGFR-Targeted Strategies in Advanced UBC
    • Roundtable Discussion (1:35:35)
    • Faculty Presentation — Dr Sonpavde (1:45:18)

CME information and select publications